hake white
Selected indexed studies
- The genetic architecture of the human cerebral cortex. (Science, 2020) [PMID:32193296]
- Genetic modifiers of APOE-ε4-associated cognitive decline. (Nat Commun, 2026) [PMID:41720779]
- Etiology of White Matter Hyperintensities in Autosomal Dominant and Sporadic Alzheimer Disease. (JAMA Neurol, 2023) [PMID:37843849]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- The genetic architecture of the human cerebral cortex. (2020) pubmed
- Genetic modifiers of APOE-ε4-associated cognitive decline. (2026) pubmed
- Etiology of White Matter Hyperintensities in Autosomal Dominant and Sporadic Alzheimer Disease. (2023) pubmed
- Characterizing Heterogeneity in Neuroimaging, Cognition, Clinical Symptoms, and Genetics Among Patients With Late-Life Depression. (2022) pubmed
- Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis. (2022) pubmed
- Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. (2023) pubmed
- Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. (2023) pubmed
- Higher Educational Attainment and Accelerated Tau Accumulation in Alzheimer Disease. (2025) pubmed
- Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease. (2014) pubmed
- Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. (2024) pubmed